Literature DB >> 30113875

Organoids for Drug Discovery and Personalized Medicine.

Toshio Takahashi1.   

Abstract

A wide variety of organs are in a dynamic state, continuously undergoing renewal as a result of constant growth and differentiation. Stem cells are required during these dynamic events for continuous tissue maintenance within the organs. In a steady state of production and loss of cells within these tissues, new cells are constantly formed by differentiation from stem cells. Today, organoids derived from either adult stem cells or pluripotent stem cells can be grown to resemble various organs. As they are similar to their original organs, organoids hold great promise for use in medical research and the development of new treatments. Furthermore, they have already been utilized in the clinic, enabling personalized medicine for inflammatory bowel disease. In this review, I provide an update on current organoid technology and summarize the application of organoids in basic research, disease modeling, drug development, personalized treatment, and regenerative medicine.

Entities:  

Keywords:  Wnt; acetylcholine; drug screening; organoid; personalized medicine; stem cell

Mesh:

Year:  2018        PMID: 30113875     DOI: 10.1146/annurev-pharmtox-010818-021108

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  42 in total

1.  Mouse models usher in precision medicine.

Authors:  Defu Zeng
Journal:  Blood       Date:  2020-06-25       Impact factor: 22.113

2.  Unifying synthetic embryology.

Authors:  Jake Cornwall-Scoones; Magdalena Zernicka-Goetz
Journal:  Dev Biol       Date:  2021-03-20       Impact factor: 3.582

3.  Tissue Engineering for Musculoskeletal Regeneration and Disease Modeling.

Authors:  Zhong Li; Shiqi Xiang; Eileen N Li; Madalyn R Fritch; Peter G Alexander; Hang Lin; Rocky S Tuan
Journal:  Handb Exp Pharmacol       Date:  2021

Review 4.  Graphene nanostructures for input-output bioelectronics.

Authors:  Raghav Garg; Daniel San Roman; Yingqiao Wang; Devora Cohen-Karni; Tzahi Cohen-Karni
Journal:  Biophys Rev       Date:  2021-12-29

Review 5.  Therapies for rare diseases: therapeutic modalities, progress and challenges ahead.

Authors:  Erik Tambuyzer; Benjamin Vandendriessche; Christopher P Austin; Philip J Brooks; Kristina Larsson; Katherine I Miller Needleman; James Valentine; Kay Davies; Stephen C Groft; Robert Preti; Tudor I Oprea; Marco Prunotto
Journal:  Nat Rev Drug Discov       Date:  2019-12-13       Impact factor: 84.694

Review 6.  Advances in development and application of human organoids.

Authors:  Abhijith Shankaran; Keshava Prasad; Sima Chaudhari; Angela Brand; Kapaettu Satyamoorthy
Journal:  3 Biotech       Date:  2021-05-08       Impact factor: 2.406

Review 7.  In Vitro Strategies to Vascularize 3D Physiologically Relevant Models.

Authors:  Alessandra Dellaquila; Chau Le Bao; Didier Letourneur; Teresa Simon-Yarza
Journal:  Adv Sci (Weinh)       Date:  2021-08-05       Impact factor: 16.806

Review 8.  In Vitro Glioblastoma Models: A Journey into the Third Dimension.

Authors:  Mayra Paolillo; Sergio Comincini; Sergio Schinelli
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

9.  Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing.

Authors:  Jianling Bi; Andreea M Newtson; Yuping Zhang; Eric J Devor; Megan I Samuelson; Kristina W Thiel; Kimberly K Leslie
Journal:  Cancers (Basel)       Date:  2021-06-10       Impact factor: 6.639

Review 10.  Reconstructing the tumor architecture into organoids.

Authors:  Zhimin Luo; Xingwu Zhou; Kalpana Mandal; Na He; Wally Wennerberg; Moyuan Qu; Xing Jiang; Wujin Sun; Ali Khademhosseini
Journal:  Adv Drug Deliv Rev       Date:  2021-06-19       Impact factor: 17.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.